Literature DB >> 1644889

Protein purification using combined streptavidin (or avidin)-Sepharose and thiopropyl-Sepharose affinity chromatography.

F Desarnaud1, J Marie, R Larguier, C Lombard, S Jard, J C Bonnafous.   

Abstract

The major problem usually encountered in the application of the (strept)avidin-biotin system to the purification of proteins (or other biological molecules) lies in the difficult reversion of the interaction between immobilized (strept)avidin and the adsorbed biotinylated protein. Among the proposed solutions is the selective biotinylation of the entity to be purified by a disulphide-containing biotinylated reagent which allows its recovery from (strept)avidin gels by dithiothreitol (DTT) treatment. As emphasized by the example of angiotensin II receptor purification, achieved using this strategy, optimum reduction of this disulphide bridge may require improvement of its accessibility using denaturating agents such as sodium dodecyl sulphate or urea. However, these agents release important amounts of (strept)avidin. Two general ways of solving this problem are proposed. One solution takes advantage of the absence of cysteine in the streptavidin sequence: the protein to be purified is selectively readsorbed to thiopropyl-Sepharose through the thiol function generated on DTT cleavage of the biotinylated reagent. The other solution is an empirical approach to make possible the use of avidin, which possesses cysteine residues: combined avidin-Sepharose and thiopropyl-Sepharose chromatography proved efficient when carried out in the presence of urea as denaturing agent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644889     DOI: 10.1016/0021-9673(92)85349-x

Source DB:  PubMed          Journal:  J Chromatogr


  1 in total

1.  Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin.

Authors:  Ryan J Austin; Heidi M Smidansky; Carly A Holstein; Deborah K Chang; Angela Epp; Neil C Josephson; Daniel B Martin
Journal:  Proteomics       Date:  2011-12-12       Impact factor: 3.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.